Recruiting
Phase 2

SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST

Sponsor:

Sarcoma Alliance for Research through Collaboration

Code:

NCT06208748

Conditions

Gastrointestinal Stromal Tumors

GIST

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bezuclastinib in combination with sunitinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information